# Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy Subjects

> **NCT04793295** · PHASE1 · COMPLETED · sponsor: **Tanabe Pharma America, Inc.** · enrollment: 112 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** MT-7117

## Key facts

- **NCT ID:** NCT04793295
- **Lead sponsor:** Tanabe Pharma America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-23
- **Primary completion:** 2022-02-04
- **Final completion:** 2022-02-04
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2023-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04793295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04793295, "Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04793295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*